Cargando…
Development of Nectin4/FAP-targeted CAR-T cells secreting IL-7, CCL19, and IL-12 for malignant solid tumors
BACKGROUND: Chimeric antigen receptor T (CAR-T) cell therapy has made significant advances for hematological malignancies but encounters obstacles in the treatment of solid tumors mainly due to tumor immunosuppressive microenvironment. METHODS: Immunohistochemistry analysis was performed to examine...
Autores principales: | Li, Fanfan, Zhao, Shuping, Wei, Cheng, Hu, Yaodi, Xu, Tianlong, Xin, Xueyi, Zhu, Tingwei, Shang, Liting, Ke, Shanwen, Zhou, Jiang, Xu, Xiaojun, Gao, Yue, Zhao, Ai, Gao, Jimin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9720259/ https://www.ncbi.nlm.nih.gov/pubmed/36479116 http://dx.doi.org/10.3389/fimmu.2022.958082 |
Ejemplares similares
-
The BCMA-Targeted Fourth-Generation CAR-T Cells Secreting IL-7 and CCL19 for Therapy of Refractory/Recurrent Multiple Myeloma
por: Duan, Deming, et al.
Publicado: (2021) -
IL-7 and CCL19-secreting CAR-T cell therapy for tumors with positive glypican-3 or mesothelin
por: Pang, Nengzhi, et al.
Publicado: (2021) -
Distinct CCL2, CCL5, CCL11, CCL27, IL-17, IL-6, BDNF serum profiles correlate to different job-stress outcomes
por: Polacchini, Alessio, et al.
Publicado: (2018) -
Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18
por: Hu, Biliang, et al.
Publicado: (2017) -
IL-15 Enhances the Persistence and Function of BCMA-Targeting CAR-T Cells Compared to IL-2 or IL-15/IL-7 by Limiting CAR-T Cell Dysfunction and Differentiation
por: Battram, Anthony M., et al.
Publicado: (2021)